Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
3 Promising Penny Stocks With Market Caps Under US$300M [Yahoo! Finance]
Innate Pharma S.A. (NASDAQ: IPHA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.50 price target on the stock.
Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma